EMTRAIN

Lead by Astra Zeneca

EMTRAIN will establish a pan-European platform for education and training covering the whole lifecycle of medicines from basic research through clinical development to pharmaco-vigilance. The public consortium consists of the six pan-European biomedical research infrastructures from the ESFRI roadmap, that cover a broad spectrum of competencies from molecules to humans, with a pan-European dimension. The EFPIA consortium has considerable experience in training and education, management, pan-European geographical outreach, and an extensive external network of contacts. The participants, together with the coordinators of IMI&T topics will participate in the Strategic Co-ordination Board to ensure coordination between the IMI&T topics whereas the Steering Committee will supervise the management of the project. E&T (Education and Training) topics representatives will be invited to participate in work packages activities. Based on extensive mapping of existing resources and on a gap and overlap analysis (Work Package 3) the consortium will develop and implement a strategy for harmonisation and accreditation (Work Package 4) of Master level Work Package 5) and PhD programmes (Work Package 6) as well as continuous education programmes (Work Package 7). It will develop innovative concepts and methods in conjunction with the other topics (Work Package 8) that will support the content for the IMI education programmes. National implementation will be facilitated through contacts with university authorities, ministries of higher education, and through national liaison offices. After implementation in a core group of institutions, extension is planned both within countries represented and in additional countries (Work Package 4), with the support of a dissemination and communication activity (Work Package 9) The harmonisation and the modular nature of these programmes will allow trans-disciplinary curricula as well as trans-border mobility, and PhD programmes will be designed to foster industry/academia mobility and collaboration.

List of Participants

AstraZeneca, Genzyme, Novartis, Bayer, Pfizer, Roche, GSK, UCB, Novo Nordisk, Sanofi, Boehringer Ingelheim, Janssen Pharmaceuticals, Orion, Almirall, Ludnbeck, Esteve, Medizinische Universität Wien (ECRINpartner), Karolinska Insititute (EATRIS partner), KUK (ECRIN partner), UniMan (BBMRI partner) ECRIN-ERIC, BBMRI-ERIC, EMBL-EBI (ELIXIR partner), HZI (EATRIS partner), GIE-CERBM (Infrafrontier partner), UOX (Instruct partner), MRC-HU (ECRIN partner) Institute of Human Virology, Nigeria